Clinical trial
Special Drug Use Investigation for ADOAIR DISKUS COPD (Salmeterol and Fluticasone)
NCT01332409 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Special Drug Use Investigation for ADOAIR DISKUS COPD (Salmeterol and Fluticasone)
- Lead sponsor
- GlaxoSmithKline
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2009
- Completion date
- January 31, 2013
- Enrollment
- 2,000 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.